These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36266272)

  • 1. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
    Herbst SA; Vesterlund M; Helmboldt AJ; Jafari R; Siavelis I; Stahl M; Schitter EC; Liebers N; Brinkmann BJ; Czernilofsky F; Roider T; Bruch PM; Iskar M; Kittai A; Huang Y; Lu J; Richter S; Mermelekas G; Umer HM; Knoll M; Kolb C; Lenze A; Cao X; Österholm C; Wahnschaffe L; Herling C; Scheinost S; Ganzinger M; Mansouri L; Kriegsmann K; Kriegsmann M; Anders S; Zapatka M; Del Poeta G; Zucchetto A; Bomben R; Gattei V; Dreger P; Woyach J; Herling M; Müller-Tidow C; Rosenquist R; Stilgenbauer S; Zenz T; Huber W; Tausch E; Lehtiö J; Dietrich S
    Nat Commun; 2022 Oct; 13(1):6226. PubMed ID: 36266272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein landscape of chronic lymphocytic leukemia.
    Meier-Abt F; Lu J; Cannizzaro E; Pohly MF; Kummer S; Pfammatter S; Kunz L; Collins BC; Nadeu F; Lee KS; Xue P; Gwerder M; Roiss M; Hüllein J; Scheinost S; Dietrich S; Campo E; Huber W; Aebersold R; Zenz T
    Blood; 2021 Dec; 138(24):2514-2525. PubMed ID: 34189564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of altered cell signaling pathways using proteomic profiling in stable and progressive chronic lymphocytic leukemia.
    Bagacean C; Iuga CA; Bordron A; Tempescul A; Pralea IE; Bernard D; Cornen M; Bergot T; Le Dantec C; Brooks W; Saad H; Ianotto JC; Pers JO; Zdrenghea M; Berthou C; Renaudineau Y
    J Leukoc Biol; 2022 Feb; 111(2):313-325. PubMed ID: 34288092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
    Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
    Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.
    Lu J; Cannizzaro E; Meier-Abt F; Scheinost S; Bruch PM; Giles HA; Lütge A; Hüllein J; Wagner L; Giacopelli B; Nadeu F; Delgado J; Campo E; Mangolini M; Ringshausen I; Böttcher M; Mougiakakos D; Jacobs A; Bodenmiller B; Dietrich S; Oakes CC; Zenz T; Huber W
    Nat Cancer; 2021 Aug; 2(8):853-864. PubMed ID: 34423310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia.
    Thurgood LA; Chataway TK; Lower KM; Kuss BJ
    J Proteomics; 2017 Feb; 155():73-84. PubMed ID: 28069558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.
    Eagle GL; Herbert JMJ; Zhuang J; Oates M; Khan UT; Kitteringham NR; Clarke K; Park BK; Pettitt AR; Jenkins RE; Falciani F
    Sci Rep; 2021 Feb; 11(1):2932. PubMed ID: 33536534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
    Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells.
    Vangapandu HV; Chen H; Wierda WG; Keating MJ; Korkut A; Gandhi V
    Leuk Lymphoma; 2018 Jun; 59(6):1427-1438. PubMed ID: 28971726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
    Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
    Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.
    Eagle GL; Zhuang J; Jenkins RE; Till KJ; Jithesh PV; Lin K; Johnson GG; Oates M; Park K; Kitteringham NR; Pettitt AR
    Mol Cell Proteomics; 2015 Apr; 14(4):933-45. PubMed ID: 25645933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
    Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
    Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
    Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
    Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia.
    Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
    J Transl Med; 2021 Jan; 19(1):42. PubMed ID: 33485349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.